June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Nucleoside reverse transcriptase inhibitor (NRTI) protection against iron cytotoxicity
Author Affiliations & Notes
  • Charles B Wright
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Younghee Kim
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Tetsuhiro Yasuma
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Reo Yasuma
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Shengjian Li
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Benjamin J Fowler
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
    Physiology, University of Kentucky, Lexington, KY
  • Ana Bastos-Carvalho
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Mark Ellsworth Kleinman
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
  • Jayakrishna Ambati
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
    Physiology, University of Kentucky, Lexington, KY
  • Bradley D Gelfand
    Ophthalmology & Visual Sciences, University of Kentucky, Lexington, KY
    Biomedical Engineering, University of Kentucky, Lexington, KY
  • Footnotes
    Commercial Relationships Charles Wright, None; Younghee Kim, None; Tetsuhiro Yasuma, None; Reo Yasuma, None; Shengjian Li, None; Benjamin Fowler, None; Ana Bastos-Carvalho, None; Mark Kleinman, None; Jayakrishna Ambati, iVeena (I); Bradley Gelfand, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4211. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Charles B Wright, Younghee Kim, Tetsuhiro Yasuma, Reo Yasuma, Shengjian Li, Benjamin J Fowler, Ana Bastos-Carvalho, Mark Ellsworth Kleinman, Jayakrishna Ambati, Bradley D Gelfand; Nucleoside reverse transcriptase inhibitor (NRTI) protection against iron cytotoxicity. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4211.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Iron-induced toxicity is implicated in multiple diseases, including age-related macular degeneration (AMD). This toxicity has been attributed to reactive oxygen species (ROS) generation through Fenton chemistry. Given the role of ROS in NLRP3 inflammasome activation, we hypothesized that the inflammasome was also involved in cytotoxicity.

Methods: Antibody staining of NLRP3 was performed in mice deficient in the iron transporters Ceruloplasmin (Cp) and Hephaestin (Heph). Metal overload was performed by media supplementation or subretinal injection in cell culture or mice, respectively. RPE cell integrity was assessed by zona occludens 1 (ZO-1) staining. Quantitative PCR (qPCR) and western blotting were performed to detect inflammasome priming and activation, respectively. Alu, B1, and B2 RNA accumulation was detected by Northern blotting or in situ hybridization (ISH). Degradation of Alu RNA in cells was detected by Northern blotting following transfection of a synthetic labeled Alu RNA. Poly(C)-binding protein 2 (PCBP2) binding of Alu RNA was assessed by pulldown assay and immunoprecipitation. Recombinant DICER1 and PCBP2 protein were used to assess in vitro cleavage efficiency of Alu RNA. The nucleoside reverse transcriptase inhibitor (NRTI) d4T was administered following iron overload.

Results: Mice deficient in iron transport proteins showed increased NLRP3 retinal staining and B1/B2 RNA staining. Fenton-capable metals all disrupted RPE cell integrity, but only iron toxicity was protected by genetic ablation of Nlrp3 or Casp1/Casp11. Inflammasome activation was specific to iron overload. Iron overload of human RPE cells and mouse eyes induced Alu RNA accumulation and B1 and B2 RNA accumulation, respectively. Iron overload did not affect Alu RNA transcription but impaired Alu RNA degradation. PCBP2 bound to Alu RNA and enhanced DICER1-mediated degradation of Alu RNA, but iron inhibited both. d4T administration protected the RPE against iron overload.

Conclusions: Iron is a novel NLRP3 inflammasome agonist, and metal-induced inflammasome activation is unique to iron. PCBP2 binds Alu RNA and is required for efficient degradation of Alu RNA by DICER1. The NRTI d4T was found to protect against RPE degeneration following iron overload. These results suggest that inflammasome activation may contribute to iron toxicity, and that NRTI therapy may be effective in other diseases of iron metabolism.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×